Pharmacological Reviews xPharm- The Comprehensive Pharmacology Reference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Erratum for Suh and Checler, Pharmacol Rev 54 (3) 469-525.

0031-6997/06/5802-280-$7.00
Pharmacol Rev 58:280, 2006

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

Erratum

Correction to "Amyloid Precursor Protein, Presenilins, and {alpha}-Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease"

As discussed in the "Notice of Concern" published in this issue, several paragraphs in the above article [Suh Y-H and Checler F (2002) Pharmacol Rev 54:469-526] were republished from an earlier work [Selkoe DJ (2001) Clearing the brain's amyloid cobwebs. Neuron 32:177-180] without attribution. Drs. Suh and Checler have provided the following comments and corrections.

Dr. Suh would like to clearly state that the material used from the Selkoe publication without attribution was an inappropriate and unacceptable action and that Dr. Checler was absolutely not involved in the written part taken from Selkoe's article.

While editing the text and references, citations of Selkoe's Neuron article at some places in the text and the entry for the Neuron article in the references were deleted as a result of the authors' mistakes and carelessness.

Dr. Suh sincerely wants to correct the text with appropriate citations as follows.

On page 477, in the left column, after "a. Insulin-Degrading Enzyme," quotation marks should enclose the text following the heading until the end of the next paragraph, and the citation "(Selkoe, 2001b)" should be added at the end of the quotation.

On page 477, in the first paragraph of the right column, the text beginning with "The intracerebral injection of synthetic Abeta peptides" to the end of the next paragraph should be in quotation marks.

On page 478, in the left column, after "d. Endothelin-Converting Enzyme," quotation marks should enclose the text following the heading until the end of the paragraph, and the citation "(Selkoe, 2001b)" should be added at the end of the quotation.

On page 522, the following reference should be added: "Selkoe DJ (2001b) Clearing the brain's amyloid cobwebs. Neuron 32:177-180."





This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition
Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics